Lessinger J M, Dourson J L, Férard G
Laboratoire de Biochimie Appliquée, UFR des Sciences Pharmaceutiques, Université Louis Pasteur de Strasbourg, Illkirch, France.
Clin Chem. 1996 Dec;42(12):1979-83.
Comparability of lipase catalytic activities was poor when lipase was determined in 50 patients' specimens by a turbidimetric (Boehringer) and a colorimetric (Sigma) assay. Mean values of results differed by a ratio of 2.39. Optimal common conditions were defined for the titration of lipase activity in two commercial calibrators and in a home-purified preparation of human pancreatic lipase (HPL). When using these titers for each calibrator, comparability was greatly improved (ratio = 1.25). This result indicates that a significant part of between-method discrepancy is due to the lack of a reference method for the titration of lipase calibrators. Intermethod behavior of each material was compared with that of patients' specimens. By using HPL as calibrator, comparability was still dramatically improved (ratio = 1.01). This study shows the importance of the validation of a material for defined routine measurement procedures, before its use as calibrator.
采用比浊法(勃林格公司)和比色法(西格玛公司)对50例患者样本中的脂肪酶进行检测时,脂肪酶催化活性的可比性较差。结果的平均值相差2.39倍。针对两种市售校准品以及自制纯化人胰脂肪酶(HPL)制剂中脂肪酶活性的滴定,确定了最佳通用条件。当对每种校准品使用这些滴定值时,可比性得到了极大提高(比值 = 1.25)。该结果表明,方法间差异的很大一部分是由于缺乏脂肪酶校准品滴定的参考方法所致。将每种材料的方法间行为与患者样本的进行了比较。以HPL作为校准品时,可比性仍显著提高(比值 = 1.01)。本研究表明,在将一种材料用作校准品之前,针对特定常规测量程序对其进行验证非常重要。